From low-density lipoprotein to platelet activation

被引:49
作者
Akkerman, Jan Willem N. [1 ]
机构
[1] Univ Utrecht, Univ Med Ctr Utrecht, Dept Clin Chem & Haematol G03 550, NL-3584 CX Utrecht, Netherlands
关键词
platelet; low-density lipoprotein (LDL); ApoE receptor2; CD36; Scavenger receptor A; p38MAPK;
D O I
10.1016/j.biocel.2008.04.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There is a strong correlation between the level of plasma low-density lipoprotein (LDL) and death by cardiovascular disease (CVD). As a main carrier of cholesterol, a high low-density lipoprotein concentration stimulates atherogenesis by its capacity to become oxidized and to become endocytosed by macrophages in the vessel wall forming cholesterol-rich plaques that are sites for arterial occlusion. New evidence points at a second role of low-density lipoprotein in increasing cardiovascular disease-risk. Contact with low-density lipoprotein induces platelet hypersensitivity to agonists that initiate platelet functions thereby enhancing adhesion, aggregation and secretion of granule contents. The signalling pathways that mediate the priming of platelets by native and oxidized low-density lipoprotein have now been characterized. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2374 / 2378
页数:5
相关论文
共 23 条
[1]   Identification of the principal proteoglycan-binding site in LDL -: A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding [J].
Borén, J ;
Olin, K ;
Lee, I ;
Chait, A ;
Wight, TN ;
Innerarity, TL .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (12) :2658-2664
[2]   Scavenger receptor a and CD36 are implicated in mediating platelet activation induced by oxidized low-density lipoproteins [J].
Collot-Teixeira, Sophie ;
Delorenzo, Ferrucio ;
McGregor, John L. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (12) :2491-2492
[3]  
Essler M, 2000, ANN NY ACAD SCI, V905, P282
[4]   Low-density lipoprotein enhances platelet secretion via integrin-αIIBβ3-mediated signaling [J].
Hackeng, CM ;
Huigsloot, M ;
Pladet, MW ;
Nieuwenhuis, HK ;
van Rijn, HJ ;
Akkerman, JWN .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (02) :239-247
[5]   Low density lipoprotein phosphorylates the focal adhesion-associated kinase p125FAK in human plate independent of integrin αIIbβ3 [J].
Hackeng, CM ;
Pladet, MW ;
Akkerman, JWN ;
van Rijn, HJM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (01) :384-388
[6]   Low-density lipoprotein activates the small GTPases Rap1 and Ral in human platelets [J].
Hackeng, CM ;
Franke, B ;
Relou, IAM ;
Gorter, G ;
Bos, JL ;
van Rijn, HJM ;
Akkerman, JWN .
BIOCHEMICAL JOURNAL, 2000, 349 (01) :231-238
[7]   Early platelet activation by low density lipoprotein via p38MAP kinase [J].
Hackeng, CM ;
Relou, IAM ;
Pladet, MW ;
Gorter, G ;
van Rijn, HJM ;
Akkerman, JWN .
THROMBOSIS AND HAEMOSTASIS, 1999, 82 (06) :1749-1756
[8]  
Korporaal S. J. A., 2006, Cardiovascular & Hematological Agents in Medicinal Chemistry, V4, P93, DOI 10.2174/187152506776369944
[9]   Binding of low density lipoprotein to platelet apolipoprotein E receptor 2′ results in phosphorylation of p38MAPK [J].
Korporaal, SJA ;
Relou, IAM ;
van Eck, M ;
Strasser, V ;
Bezemer, M ;
Gorter, G ;
van Berkel, TJC ;
Nimpf, J ;
Akkerman, JWN ;
Lenting, PJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (50) :52526-52534
[10]  
Korporaal SJA, 2005, ARTERIOSCLER THROMB, V25, P1